Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prevalence and the Prognosis of Resistant Hypertension Ascertained With Systemic Investigation and Optimal Treatment With Antihypertensive Drugs

NCT01703780 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences, Fuwai Hospital as lead sponsor.

NCT NCT01703780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01703780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prevalence and the Prognosis of Resistant Hypertension Ascertained With Systemic Investigation and Optimal Treatment With Antihypertensive Drugs
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2012
Completion date
December 31, 2018
Enrollment
9,638 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, resistant to conventional therapy